Insider Trading activities at Therapeuticsmd, Inc. (TXMD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Therapeuticsmd, Inc. (TXMD) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Therapeuticsmd, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 25743.

Total stock buying since 2005: $259,208,245.
Total stock sales since 2005: $89,632,808.
Total stock option exercises since 2005: $765,311.


 1   2 
31 insiders reported insider trading activities at Therapeuticsmd, Inc. (TXMD):
Insider trading activities of Tjon Robin Natalie
Insider trading activities of Rosen David Efraim
Insider trading activities of Glickman Mark A
Insider trading activities of Jensen Julian D
Insider trading activities of Walker Marlan D
Insider trading activities of Jensen Gerald L
Insider trading activities of Jensen Development Co
Insider trading activities of Naughton Gail K
Insider trading activities of Thompson Tommy G
Insider trading activities of Mastropietro Donald R
Insider trading activities of Lapenta Robert V Jr
Insider trading activities of Mandel Richard H Jr
Insider trading activities of Croff Enterprises Inc
Insider trading activities of Segal Nicholas
Insider trading activities of Musing Jules A.
Insider trading activities of Collins Cooper C.
Insider trading activities of Borkowski Edward
Insider trading activities of Donegan Michael C
Insider trading activities of Finizio Robert G
Insider trading activities of Bernick Brian
Insider trading activities of Krassan Mitchell
Insider trading activities of Carroll J Martin
Insider trading activities of Cartwright Daniel A
Insider trading activities of Bisaro Paul
Insider trading activities of Milligan John C.k. Iv
Insider trading activities of Darecca James
Insider trading activities of Russell Angus C.
Insider trading activities of Ling Karen
Insider trading activities of Sarubbi Kimberly
Insider trading activities of Barlow Jane F
Insider trading activities of C.s. Finance Llc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Therapeuticsmd, Inc. (TXMD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 3,118 $2,808 0 $0 33,781 $0
2024 5,294 $9,136 0 $0 0 $0
2023 0 $0 23,226 $63,564 137,813 $0
2022 711,818 $254,483,089 36,575 $38,695,949 255,811 $0
2021 2,099,445 $1,383,453 279,328 $259,588 1,520,845 $0
2020 208,700 $275,019 300,000 $676,799 300,000 $58,800
2019 598,237 $1,716,695 17,400 $100,920 0 $0
2018 4,000 $22,100 5,048,075 $26,671,252 5,048,075 $537,129
2017 10,000 $61,000 0 $0 0 $0
2016 16,000 $99,712 0 $0 0 $0
2015 75,298 $461,706 90,000 $638,760 90,000 $17,340
2014 40,757 $154,717 4,036,347 $14,769,723 136,526 $152,042
2013 122,046 $204,419 4,231,579 $7,085,263 0 $0
2010 0 $0 8,900,898 $172,540 0 $0
2008 0 $0 281,625 $410,355 0 $0
2007 4,380 $11,871 0 $0 0 $0
2006 2,000 $4,855 0 $0 0 $0
2005 107,415 $317,665 29,365 $88,095 0 $0

Table 2. Monthly summary of insider trading at Therapeuticsmd, Inc. (TXMD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-04 3,118 $2,808 0 $0 0 $0
2025-02 0 $0 0 $0 33,781 $0
2024-08 5,294 $9,136 0 $0 0 $0
2023-12 0 $0 19,050 $43,682 70,000 $0
2023-04 0 $0 1,170 $4,275 57,508 $0
2023-01 0 $0 3,006 $15,607 10,305 $0
2022-12 35,238 $205,932 36,575 $38,695,949 10,931 $0
2022-10 7,000 $7,000,000 0 $0 0 $0
2022-09 7,000 $7,000,000 0 $0 0 $0
2022-08 0 $0 0 $0 14,880 $0
2022-07 662,580 $240,277,157 0 $0 0 $0
2022-03 0 $0 0 $0 230,000 $0
2021-11 1,000,000 $579,000 29,790 $15,937 115,000 $0
2021-08 1,094,445 $799,153 93,337 $81,203 1,040,511 $0
2021-05 5,000 $5,300 156,201 $162,448 365,334 $0
2020-06 208,700 $275,019 0 $0 0 $0
2020-02 0 $0 300,000 $676,799 300,000 $58,800
2019-10 324,000 $891,000 0 $0 0 $0
2019-08 241,837 $717,809 0 $0 0 $0
2019-05 32,400 $107,886 0 $0 0 $0
2019-02 0 $0 17,400 $100,920 0 $0
2018-12 0 $0 1,199,747 $5,123,164 1,199,747 $133,490
2018-11 0 $0 1,381,128 $6,717,653 1,381,128 $151,991
2018-10 0 $0 1,233,600 $6,889,870 1,233,600 $125,824

Table 3. Detailed insider trading at Therapeuticsmd, Inc. (TXMD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-04-14 Walker Marlan D (Chief Executive Officer) Buy 490 1.00 489
2025-04-14 Thompson Tommy G Buy 325 1.00 325
2025-04-10 Walker Marlan D (Chief Executive Officer) Buy 1,167 .86 1,000
2025-04-09 Walker Marlan D (Chief Executive Officer) Buy 1,136 .88 994
2025-02-18 Walker Marlan D (Chief Executive Officer) Option Ex 8,281 .00 0
2025-02-18 Collins Cooper C. Option Ex 8,500 .00 0
2025-02-18 Thompson Tommy G Option Ex 8,500 .00 0
2025-02-18 Naughton Gail K Option Ex 8,500 .00 0
2024-08-22 Collins Cooper C. Buy 4,094 1.73 7,098
2024-08-21 Collins Cooper C. Buy 1,200 1.70 2,038
2023-12-07 Walker Marlan D (Chief Executive Officer) Sale 4,550 2.24 10,187
2023-12-06 Walker Marlan D (Chief Executive Officer) Sale 14,500 2.31 33,495
2023-12-05 Walker Marlan D (Chief Executive Officer) Option Ex 70,000 .00 0
2023-04-12 Walker Marlan D (Chief Executive Officer) Sale 1,170 3.65 4,275
2023-04-12 Walker Marlan D (Chief Executive Officer) Option Ex 7,508 .00 0
2023-04-12 Donegan Michael C (Prin. Fin. and Acctg. Officer) Option Ex 50,000 .00 0
2023-01-27 Donegan Michael C (Prin. Fin. and Acctg. Officer) Sale 49 5.09 249
2023-01-26 Donegan Michael C (Prin. Fin. and Acctg. Officer) Sale 1,648 5.08 8,371
2023-01-26 Donegan Michael C (Prin. Fin. and Acctg. Officer) Option Ex 5,940 .00 0
2023-01-24 Donegan Michael C (Prin. Fin. and Acctg. Officer) Sale 7 5.31 37
2023-01-23 Donegan Michael C (Prin. Fin. and Acctg. Officer) Sale 1,302 5.34 6,950
2023-01-23 Donegan Michael C (Prin. Fin. and Acctg. Officer) Option Ex 4,365 .00 0
2022-12-30 Rosen David Efraim Sale 29,000 1,333.00 38,657,000
2022-12-09 Rosen David Efraim Buy 14,825 6.09 90,284
2022-12-09 Bernick Brian (Co-Chief Executive Officer) Sale 320 6.31 2,019
2022-12-08 Rosen David Efraim Buy 300 5.83 1,749
2022-12-07 Rosen David Efraim Buy 20,113 5.66 113,899
2022-12-07 Naughton Gail K (Director) Sale 3,922 5.26 20,633
2022-12-06 Walker Marlan D (General Counsel) Sale 1,048 4.95 5,185
2022-12-06 Walker Marlan D (General Counsel) Option Ex 2,554 .00 0
2022-12-06 Donegan Michael C (Interim CFO/CAO/VP of Finance) Sale 910 4.78 4,345
2022-12-06 Donegan Michael C (Interim CFO/CAO/VP of Finance) Option Ex 3,476 .00 0
2022-12-06 Bernick Brian (Co-Chief Executive Officer) Sale 935 4.92 4,602
2022-12-06 Bernick Brian (Co-Chief Executive Officer) Option Ex 3,167 .00 0
2022-12-06 Glickman Mark A (Co-Chief Executive Officer) Sale 440 4.92 2,165
2022-12-06 Glickman Mark A (Co-Chief Executive Officer) Option Ex 1,734 .00 0
2022-10-28 Rosen David Efraim Buy 7,000 1,000.00 7,000,000
2022-09-30 Rosen David Efraim Buy 7,000 1,000.00 7,000,000
2022-08-18 Ling Karen (Director) Option Ex 1,984 .00 0
2022-08-18 Russell Angus C. (Director) Option Ex 1,984 .00 0
2022-08-18 Musing Jules A. (Director) Option Ex 1,984 .00 0
2022-08-18 Collins Cooper C. (Director) Option Ex 1,984 .00 0
2022-08-18 Thompson Tommy G (Director) Option Ex 2,976 .00 0
2022-08-18 Naughton Gail K (Director) Option Ex 1,984 .00 0
2022-08-18 Bisaro Paul (Director) Option Ex 1,984 .00 0
2022-07-29 Rosen David Efraim Buy 580,000 413.46 239,809,700
2022-07-18 Rosen David Efraim Buy 17,688 6.03 106,658
2022-07-15 Rosen David Efraim Buy 64,892 5.56 360,799
2022-03-14 Walker Marlan D (General Counsel) Option Ex 230,000 .00 0
2021-11-30 Donegan Michael C (CAO and VP of Finance) Sale 29,790 .54 15,937
2021-11-30 Donegan Michael C (CAO and VP of Finance) Option Ex 115,000 .00 0
2021-11-18 Collins Cooper C. (Director) Buy 1,000,000 .58 579,000
2021-08-18 Collins Cooper C. Buy 900,000 .72 648,000
2021-08-17 Ling Karen Buy 33,445 .75 25,083
2021-08-17 Collins Cooper C. Buy 100,000 .77 77,000
2021-08-16 Bisaro Paul Buy 50,000 .79 39,500
2021-08-13 Thompson Tommy G Buy 11,000 .87 9,570
2021-08-12 Darecca James (Chief Financial Officer) Sale 93,337 .87 81,203
2021-08-10 Ling Karen Option Ex 96,864 .00 0
2021-08-10 Darecca James (Chief Financial Officer) Option Ex 217,167 .00 0
2021-08-10 Russell Angus C. Option Ex 96,864 .00 0
2021-08-10 Musing Jules A. Option Ex 96,864 .00 0
2021-08-10 Collins Cooper C. Option Ex 96,864 .00 0
2021-08-10 Thompson Tommy G Option Ex 145,296 .00 0
2021-08-10 Naughton Gail K Option Ex 96,864 .00 0
2021-08-10 Carroll J Martin Option Ex 96,864 .00 0
2021-08-10 Bisaro Paul Option Ex 96,864 .00 0
2021-05-14 Thompson Tommy G Buy 5,000 1.06 5,300
2021-05-11 Finizio Robert G (CEO) Sale 67,697 1.04 70,404
2021-05-11 Milligan John C.k. Iv (Secretary/CEO of subsidiary) Sale 44,252 1.04 46,022
2021-05-11 Borkowski Edward (EVP, Operations) Sale 44,252 1.04 46,022
2021-05-10 Finizio Robert G (CEO) Option Ex 158,334 .00 0
2021-05-10 Milligan John C.k. Iv (Secretary/CEO of subsidiary) Option Ex 103,500 .00 0
2021-05-10 Borkowski Edward (EVP, Operations) Option Ex 103,500 .00 0
2020-06-09 Finizio Robert G (CEO) Buy 46,000 1.44 66,240
2020-06-09 Collins Cooper C. Buy 47,500 1.45 68,875
2020-06-08 Collins Cooper C. Buy 26,500 1.45 38,425
2020-06-05 Finizio Robert G (CEO) Buy 30,000 1.16 34,650
2020-06-04 Thompson Tommy G Buy 8,700 1.13 9,830
2020-06-04 Bisaro Paul Buy 50,000 1.14 56,999
2020-02-03 Krassan Mitchell (Chief Strategy Officer) Sale 300,000 2.26 676,799
2020-02-03 Krassan Mitchell (Chief Strategy Officer) Option Ex 300,000 .20 58,800
2019-10-25 Finizio Robert G (CEO) Buy 72,000 2.75 198,000
2019-10-25 Bernick Brian Buy 36,000 2.75 99,000
2019-10-25 Milligan John C.k. Iv (President/Secretary) Buy 144,000 2.75 396,000
2019-08-23 Russell Angus C. Buy 10,000 2.77 27,700
2019-08-20 Finizio Robert G (CEO) Buy 35,000 2.74 95,900
2019-08-16 Milligan John C.k. Iv (President/Secretary) Buy 10,000 2.93 29,300
2019-08-15 Russell Angus C. Buy 10,000 2.99 29,900
2019-08-14 Russell Angus C. Buy 25,000 2.76 69,000
2019-08-12 Barlow Jane F Buy 6,288 3.18 19,994
2019-08-12 Milligan John C.k. Iv (President/Secretary) Buy 45,000 3.16 142,200
2019-08-09 Finizio Robert G (CEO) Buy 52,405 2.96 155,118
2019-08-09 Bernick Brian Buy 10,000 2.87 28,700
2019-08-09 Thompson Tommy G Buy 5,000 3.04 15,200
2019-05-13 Collins Cooper C. Buy 30,000 3.33 99,870
2019-05-13 Thompson Tommy G Buy 2,400 3.34 8,016
2019-02-27 Musing Jules A. Sale 17,400 5.80 100,920
2018-12-20 Finizio Robert G (CEO) Sale 92,910 3.63 336,891
2018-12-20 Finizio Robert G (CEO) Option Ex 92,910 .10 9,476
2018-12-19 Finizio Robert G (CEO) Sale 92,000 3.70 340,216
2018-12-19 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-12-18 Milligan John C.k. Iv (President/Secretary) Sale 129,127 3.64 469,634
2018-12-18 Milligan John C.k. Iv (President/Secretary) Option Ex 129,127 .10 13,170
2018-12-17 Milligan John C.k. Iv (President/Secretary) Sale 129,000 3.75 483,750
2018-12-17 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-12-13 Bernick Brian Sale 91,910 4.12 378,577
2018-12-13 Bernick Brian Option Ex 91,910 .10 9,374
2018-12-12 Bernick Brian Sale 91,400 4.18 381,960
2018-12-12 Bernick Brian Option Ex 91,400 .10 9,322
2018-12-07 Finizio Robert G (CEO) Sale 92,000 4.60 423,568
2018-12-07 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-12-06 Finizio Robert G (CEO) Sale 92,000 4.57 420,624
2018-12-06 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-12-06 Cartwright Daniel A (CFO) Sale 40,000 4.57 182,800
2018-12-06 Cartwright Daniel A (CFO) Option Ex 40,000 .38 15,200
2018-12-06 Milligan John C.k. Iv (President/Secretary) Sale 129,000 4.57 589,530
2018-12-06 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-12-04 Milligan John C.k. Iv (President/Secretary) Sale 129,000 4.98 642,162
2018-12-04 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-12-03 Bernick Brian Sale 91,400 5.18 473,452
2018-12-03 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-30 Bernick Brian Sale 91,400 4.96 453,344
2018-11-30 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-29 Milligan John C.k. Iv (President/Secretary) Sale 129,128 5.03 650,030
2018-11-29 Milligan John C.k. Iv (President/Secretary) Option Ex 129,128 .10 13,171
2018-11-28 Milligan John C.k. Iv (President/Secretary) Sale 129,000 4.89 630,294
2018-11-28 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-11-27 Finizio Robert G (CEO) Sale 92,000 4.80 442,060
2018-11-27 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-11-26 Finizio Robert G (CEO) Sale 92,000 4.86 447,028
2018-11-26 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-11-20 Bernick Brian Sale 91,400 4.74 432,870
2018-11-20 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-19 Bernick Brian Sale 91,400 4.75 433,875
2018-11-19 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-15 Milligan John C.k. Iv (President/Secretary) Sale 129,000 4.99 643,581
2018-11-15 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-11-14 Milligan John C.k. Iv (President/Secretary) Sale 129,000 4.82 621,651
2018-11-14 Milligan John C.k. Iv (President/Secretary) Option Ex 129,000 .10 13,158
2018-11-13 Finizio Robert G (CEO) Sale 92,000 4.81 442,428
2018-11-13 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-11-12 Finizio Robert G (CEO) Sale 92,000 4.73 435,160
2018-11-12 Finizio Robert G (CEO) Option Ex 92,000 .10 9,384
2018-11-09 Bernick Brian Sale 91,400 4.83 441,096
2018-11-09 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-08 Bernick Brian Sale 91,400 4.93 450,236
2018-11-08 Bernick Brian Option Ex 91,400 .10 9,322
2018-11-07 Cartwright Daniel A (CFO) Sale 40,000 4.85 194,000
2018-11-07 Cartwright Daniel A (CFO) Option Ex 40,000 .38 15,200
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of TXMD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Therapeuticsmd, Inc. (symbol TXMD, CIK number 25743) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.